Testing the Effectiveness of a Novel Intervention to Improve Medication Adherence in Strok
The goal of this study is to test if Savvy, a multimodal intervention (consisting of psychological exercises, a weekly pill organizer, and a text message reminder system) can improve medication adherence in stroke survivors. The main questions it aims to answer are: * Can the Savvy tool improve medication adherence in
| Condition(s) | Stroke, Intracerebral Haemorrhage, Ischemic Stroke, TIA (Transient Ischemic Attack) |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of this study is to test if Savvy, a multimodal intervention (consisting of psychological exercises, a weekly pill organizer, and a text message reminder system) can improve medication adherence in stroke survivors. The main questions it aims to answer are: * Can the Savvy tool improve medication adherence in stroke survivors compared to usual care? * Does the use of the Savvy tool lead to better blood pressure control after a stroke? The investigators will compare the use of the Savvy intervention to a control group that receives usual care, including a package of educational materials. The study consists of the following components: * Participants will receive the Savvy intervention or usual care. The intervention package consists of short psychological exercises over the phone, |
| Who can participate | Inclusion criteria: 1. Participants must be between the ages of 18 years old and 99 years old at the time of consent. 2. Self-reported primary diagnosis of stroke (ischemic or hemorrhagic) within the past 12 months, without structural, traumatic or secondary causes (including aneurysm, arteriovenous malformation, or tumor). 3. Currently prescribed an antihypertensive regimen. 4. Currently less than optimal adherence to medication, defined as a score \<25 on the Medication Adherence Report Scale (MARS-5). 5. Cognitively able to manage medications independently, defined as a score of \>4 on the Six-Item Screener (SIS) for cognitive impairment. 6. Speaks English sufficiently to complete consent and study procedures. 7. Has access to a phone that can receive text messages and is able to partic |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Lead sponsor | Massachusetts General Hospital |
| Locations | Boston, Massachusetts, United States; Boston, Massachusetts, United States |
| Start date | 2026-03-31 |
| NCT ID | NCT07414732 |
| Official listing | https://clinicaltrials.gov/study/NCT07414732 |